VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1643242
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: SARS-CoV-2 test; Test Result: Positive ; Result Unstructured Data: Positive

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Has Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Has Covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Has Covid-19). At the time of the report, COVID-19 (Has Covid-19) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: positive (Positive) Positive. No concomitant medications were mentioned. The patient had the vaccine series in January and February. No treatment details were reported.

Other Meds:

Current Illness:

ID: 1643243
Sex: U
Age:
State: AR

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of peripheral swelling (swelling in arm) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced peripheral swelling (swelling in arm). At the time of the report, peripheral swelling (swelling in arm) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information provided.

Other Meds:

Current Illness:

ID: 1643244
Sex: U
Age: 44
State: MA

Vax Date: 02/22/2021
Onset Date: 03/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: tightness under left arm running through his chest and throat; Anxiety; Patient was prescribed Zoloft, Duloxetine and Celexa but could not tolerate it; felt like lymph node reacting; tightness under left arm running through his chest and throat; numbness in mouth and extremeties; numbness in extremeties; extreme brain fog; full blown panic attack; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (tightness under left arm running through his chest and throat), PANIC ATTACK (full blown panic attack), FEELING ABNORMAL (extreme brain fog), HYPOAESTHESIA ORAL (numbness in mouth and extremeties) and HYPOAESTHESIA (numbness in extremeties) in a 44-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for Anxiety, LORAZEPAM for an unknown indication. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced PANIC ATTACK (full blown panic attack), FEELING ABNORMAL (extreme brain fog), HYPOAESTHESIA ORAL (numbness in mouth and extremeties) and HYPOAESTHESIA (numbness in extremeties). On an unknown date, the patient experienced THROAT TIGHTNESS (tightness under left arm running through his chest and throat), CHEST DISCOMFORT (tightness under left arm running through his chest and throat), DRUG INTOLERANCE (Patient was prescribed Zoloft, Duloxetine and Celexa but could not tolerate it), ANXIETY (Anxiety) and LYMPHADENOPATHY (felt like lymph node reacting). The patient was treated with SERTRALINE HYDROCHLORIDE (ZOLOFT) at an unspecified dose and frequency; DULOXETINE at an unspecified dose and frequency and CELECOXIB (CELEXA [CELECOXIB]) at an unspecified dose and frequency. At the time of the report, THROAT TIGHTNESS (tightness under left arm running through his chest and throat), PANIC ATTACK (full blown panic attack), FEELING ABNORMAL (extreme brain fog), HYPOAESTHESIA ORAL (numbness in mouth and extremeties), HYPOAESTHESIA (numbness in extremeties), CHEST DISCOMFORT (tightness under left arm running through his chest and throat), DRUG INTOLERANCE (Patient was prescribed Zoloft, Duloxetine and Celexa but could not tolerate it), ANXIETY (Anxiety) and LYMPHADENOPATHY (felt like lymph node reacting) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This case was linked to MOD-2021-234546 (Patient Link).

Other Meds: LEXAPRO; LORAZEPAM

Current Illness:

ID: 1643245
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Covid hands; blisters on both hands bilaterally, & between & atop his knuckles & between his knuckles, & on knuckles/big patches of redness with tiny blisters on top of the patches; big patches of redness with tiny blisters on top of the patches / hands stay red for a long time; a lot of colitis; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE REACTION (Covid hands), BLISTER (blisters on both hands bilaterally, & between & atop his knuckles & between his knuckles, & on knuckles/big patches of redness with tiny blisters on top of the patches), ERYTHEMA (big patches of redness with tiny blisters on top of the patches / hands stay red for a long time) and COLITIS (a lot of colitis) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Colitis and COVID-19. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Covid hands), BLISTER (blisters on both hands bilaterally, & between & atop his knuckles & between his knuckles, & on knuckles/big patches of redness with tiny blisters on top of the patches), ERYTHEMA (big patches of redness with tiny blisters on top of the patches / hands stay red for a long time) and COLITIS (a lot of colitis). At the time of the report, VACCINATION SITE REACTION (Covid hands), ERYTHEMA (big patches of redness with tiny blisters on top of the patches / hands stay red for a long time) and COLITIS (a lot of colitis) outcome was unknown and BLISTER (blisters on both hands bilaterally, & between & atop his knuckles & between his knuckles, & on knuckles/big patches of redness with tiny blisters on top of the patches) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The blisters went away and patient's hand remained reddened for extended periods. The patient visited dermatologist, who admitted to having never seen this before. He prescribed multiple creams but none had been effective. No concomitant medications were provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1643246
Sex: U
Age:
State:

Vax Date:
Onset Date: 06/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Has not received the Second Shot, more than 6 weeks since first Moderna shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Has not received the Second Shot, more than 6 weeks since first Moderna shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received the Second Shot, more than 6 weeks since first Moderna shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Has not received the Second Shot, more than 6 weeks since first Moderna shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication were reported. No treatment medications were reported.

Other Meds:

Current Illness:

ID: 1643247
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Unwell; headache; dizzy; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Unwell), HEADACHE (headache) and DIZZINESS (dizzy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Unwell), HEADACHE (headache) and DIZZINESS (dizzy). At the time of the report, MALAISE (Unwell), HEADACHE (headache) and DIZZINESS (dizzy) outcome was unknown.

Other Meds:

Current Illness:

ID: 1643248
Sex: F
Age: 58
State: PR

Vax Date: 06/09/2021
Onset Date: 06/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Vaccination site warmth; Vaccination site pruritus; Vaccination site erythema; Vaccination site swelling; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE SWELLING (Vaccination site swelling ), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included LOSARTAN, METOPROLOL and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication. On 09-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jun-2021, the patient experienced VACCINATION SITE SWELLING (Vaccination site swelling ) and VACCINATION SITE PAIN (Vaccination site pain). On 20-Jun-2021, the patient experienced VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE ERYTHEMA (Vaccination site erythema). On 16-Jun-2021, VACCINATION SITE SWELLING (Vaccination site swelling ) and VACCINATION SITE PAIN (Vaccination site pain) had resolved. At the time of the report, VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided.

Other Meds: LOSARTAN; METOPROLOL; ASPIRIN (E.C.)

Current Illness:

ID: 1643249
Sex: U
Age: 44
State: MA

Vax Date: 02/22/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: TMJ in is jaw; This spontaneous case was reported by a consumer and describes the occurrence of TEMPOROMANDIBULAR JOINT SYNDROME (TMJ in is jaw) in a 44-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 001A21A) for COVID-19 vaccination. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for Anxiety, LORAZEPAM for an unknown indication. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TEMPOROMANDIBULAR JOINT SYNDROME (TMJ in is jaw). At the time of the report, TEMPOROMANDIBULAR JOINT SYNDROME (TMJ in is jaw) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient reported being in between healthcare providers and that patient had seen a neurologist. Patient consent to follow up with safety team. Patient consent to follow up with neurologist. Action taken with mRNA-1273 (COVID 19 Vaccine Moderna) was not applicable. No concomitant product reported by reporter. No treatment medication reported by reporter. This case was linked to MOD-2021-234496 (Patient Link).

Other Meds: LEXAPRO; LORAZEPAM

Current Illness:

ID: 1643250
Sex: F
Age: 28
State: MA

Vax Date: 05/11/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: IgG subclass; Test Result: Inconclusive ; Result Unstructured Data: IgG subclass were low

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Zits got infected/ tiny cuts and zits are getting infected which didn't normally happen; This spontaneous case was reported by a consumer and describes the occurrence of ACNE (Zits got infected/ tiny cuts and zits are getting infected which didn't normally happen) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination. No Medical History information was reported. Concomitant products included ZIPRASIDONE HYDROCHLORIDE (GEODON [ZIPRASIDONE HYDROCHLORIDE]), VENLAFAXINE HYDROCHLORIDE (EFFEXOR), LORAZEPAM (ATIVAN) and VITAMIN D [VITAMIN D NOS] for an unknown indication. On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, the patient experienced ACNE (Zits got infected/ tiny cuts and zits are getting infected which didn't normally happen). At the time of the report, ACNE (Zits got infected/ tiny cuts and zits are getting infected which didn't normally happen) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood immunoglobulin G: igg subclass were low (Inconclusive) IgG subclass were low. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reportedly, about two weeks after getting first dose of vaccine, one of her zits got infected. She noticed that her tiny cuts and zits were getting infected which didn't normally happen. She went to the doctor who told her to use a triple antibiotic ointment which helped but there were still scars. About 4-5 weeks ago she got labs done and they noticed her IgG subclass were low.

Other Meds: GEODON [ZIPRASIDONE HYDROCHLORIDE]; EFFEXOR; ATIVAN; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1643251
Sex: F
Age: 49
State: WA

Vax Date: 05/25/2021
Onset Date: 05/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: typical soreness on arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (typical soreness on arm) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination. No Medical History information was reported. On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced MYALGIA (typical soreness on arm). At the time of the report, MYALGIA (typical soreness on arm) had resolved. Not provided. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications reported. Treatment information not reported. This case was linked to MOD-2021-234576 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow up received and outcome of the event updated.

Other Meds:

Current Illness:

ID: 1643252
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: heart palpitations; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart palpitations) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (heart palpitations). At the time of the report, PALPITATIONS (heart palpitations) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported. Treatment medication was not provided.

Other Meds:

Current Illness:

ID: 1643253
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: hand numbness; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (hand numbness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (hand numbness). At the time of the report, HYPOAESTHESIA (hand numbness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication were provided. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1643254
Sex: F
Age: 73
State: MI

Vax Date: 06/14/2021
Onset Date: 06/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Injection site had bumps; A few red spots around the injection site/a large red spot around the injection site; A few red spots around the injection site/a large red spot around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Injection site had bumps), VACCINATION SITE ERYTHEMA (A few red spots around the injection site/a large red spot around the injection site) and VACCINATION SITE RASH (A few red spots around the injection site/a large red spot around the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21A) for COVID-19 vaccination. No Medical History information was reported. On 14-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021, the patient experienced VACCINATION SITE ERYTHEMA (A few red spots around the injection site/a large red spot around the injection site) and VACCINATION SITE RASH (A few red spots around the injection site/a large red spot around the injection site). On 24-Jun-2021, the patient experienced VACCINATION SITE MASS (Injection site had bumps). At the time of the report, VACCINATION SITE MASS (Injection site had bumps), VACCINATION SITE ERYTHEMA (A few red spots around the injection site/a large red spot around the injection site) and VACCINATION SITE RASH (A few red spots around the injection site/a large red spot around the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication were reported. No treatment information was reported

Other Meds:

Current Illness:

ID: 1643255
Sex: F
Age: 20
State: MD

Vax Date: 05/11/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Second dose not received in allowed timeframe; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second dose not received in allowed timeframe) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included ORAL CONTRACEPTIVE NOS for an unknown indication. On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second dose not received in allowed timeframe). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second dose not received in allowed timeframe) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medication were reported. No treatment medication were reported.

Other Meds: ORAL CONTRACEPTIVE NOS

Current Illness:

ID: 1643256
Sex: F
Age: 49
State: WA

Vax Date: 06/22/2021
Onset Date: 06/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: red mark like a bruise on the vaccination site; vaccination site warm to the touch; vaccination site is still red; vaccination site puffy; Body ache; chills; fever; burning; stinging; pain at vaccination site during the injection; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning), PAIN (stinging), VACCINATION SITE BRUISING (red mark like a bruise on the vaccination site), VACCINATION SITE WARMTH (vaccination site warm to the touch) and VACCINATION SITE ERYTHEMA (vaccination site is still red) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 22-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021, the patient experienced BURNING SENSATION (burning), PAIN (stinging), VACCINATION SITE PAIN (pain at vaccination site during the injection) and PYREXIA (fever). On 23-Jun-2021, the patient experienced VACCINATION SITE BRUISING (red mark like a bruise on the vaccination site), VACCINATION SITE WARMTH (vaccination site warm to the touch), VACCINATION SITE ERYTHEMA (vaccination site is still red), VACCINATION SITE SWELLING (vaccination site puffy), MYALGIA (Body ache) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 milligram. At the time of the report, BURNING SENSATION (burning), PAIN (stinging), VACCINATION SITE BRUISING (red mark like a bruise on the vaccination site), VACCINATION SITE WARMTH (vaccination site warm to the touch), VACCINATION SITE ERYTHEMA (vaccination site is still red), VACCINATION SITE SWELLING (vaccination site puffy), MYALGIA (Body ache), VACCINATION SITE PAIN (pain at vaccination site during the injection), CHILLS (chills) and PYREXIA (fever) had resolved. No concomitant medications were reported. This case was linked to MOD-2021-234551 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Outcome of event updated from unknown to recovered/resolved.

Other Meds:

Current Illness:

ID: 1643257
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: muscle aches; joint aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle aches) and ARTHRALGIA (joint aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle aches) and ARTHRALGIA (joint aches). At the time of the report, MYALGIA (muscle aches) and ARTHRALGIA (joint aches) outcome was unknown.

Other Meds:

Current Illness:

ID: 1643258
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: 3 week menstrual cycle; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (3 week menstrual cycle) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (3 week menstrual cycle). At the time of the report, HEAVY MENSTRUAL BLEEDING (3 week menstrual cycle) outcome was unknown. No concomitant medications was reported. No treatment drug details was reported.

Other Meds:

Current Illness:

ID: 1643259
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: pain from shot site; shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain from shot site) and ARTHRALGIA (shoulder pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain from shot site) and ARTHRALGIA (shoulder pain). At the time of the report, VACCINATION SITE PAIN (pain from shot site) and ARTHRALGIA (shoulder pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1643260
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of eye pruritus (itchy eyes) and eye swelling (swollen eyes) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced eye pruritus (itchy eyes) and eye swelling (swollen eyes). At the time of the report, eye pruritus (itchy eyes) and eye swelling (swollen eyes) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown.

Other Meds:

Current Illness:

ID: 1643261
Sex: F
Age: 44
State: MO

Vax Date: 04/29/2021
Onset Date: 06/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: difficulty sleeping (due to the itching and rash); hives, and it's all over her body including between her fingers; left arm rash/ rash continued all over her body (including ears, neck, chest, back, and legs)/ rash ongoing; left arm itching/ severe itching ongoing; "got sick"; fever; chills; body aches; swelling of face; swelling of ears; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (left arm itching/ severe itching ongoing), ILLNESS ("got sick"), PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. The patient's past medical history included No adverse reaction. Concurrent medical conditions included Drug allergy (doxycyclline). On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Jun-2021, the patient experienced PRURITUS (left arm itching/ severe itching ongoing), ILLNESS ("got sick"), PYREXIA (fever), CHILLS (chills), MYALGIA (body aches), SWELLING FACE (swelling of face) and EAR SWELLING (swelling of ears). On 05-Jun-2021, the patient experienced RASH (left arm rash/ rash continued all over her body (including ears, neck, chest, back, and legs)/ rash ongoing). On an unknown date, the patient experienced INSOMNIA (difficulty sleeping (due to the itching and rash)) and URTICARIA (hives, and it's all over her body including between her fingers). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, PRURITUS (left arm itching/ severe itching ongoing), ILLNESS ("got sick"), PYREXIA (fever), CHILLS (chills), MYALGIA (body aches), SWELLING FACE (swelling of face), EAR SWELLING (swelling of ears), RASH (left arm rash/ rash continued all over her body (including ears, neck, chest, back, and legs)/ rash ongoing), INSOMNIA (difficulty sleeping (due to the itching and rash)) and URTICARIA (hives, and it's all over her body including between her fingers) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. no concomitant medications reported. treatment medications included steroids injections.

Other Meds:

Current Illness:

ID: 1643262
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: swollen and sore lymph nodes; swollen and sore lymph nodes; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LYMPH NODE PAIN (swollen and sore lymph nodes) and LYMPHADENOPATHY (swollen and sore lymph nodes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPH NODE PAIN (swollen and sore lymph nodes) and LYMPHADENOPATHY (swollen and sore lymph nodes). At the time of the report, LYMPH NODE PAIN (swollen and sore lymph nodes) and LYMPHADENOPATHY (swollen and sore lymph nodes) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No Relevant concomitant medications was reported. Treatment information was not provided

Other Meds:

Current Illness:

ID: 1643263
Sex: F
Age: 77
State: TX

Vax Date: 06/17/2021
Onset Date: 06/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: patient received a vaccine which was wrong storage and handling; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received a vaccine which was wrong storage and handling) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination. No Medical History information was reported. On 17-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received a vaccine which was wrong storage and handling). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received a vaccine which was wrong storage and handling) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. the patient received remdesivir in November . Action taken with mRNA-1273 in response to the event was not applicable. Treatment information was not provided. Concomitant product use was not provided. Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Non-significant follow-up

Other Meds:

Current Illness:

ID: 1643264
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: little on my back then scratch marks; little rash on lower back; This spontaneous case was reported by a consumer and describes the occurrence of SCRATCH (little on my back then scratch marks) and RASH (little rash on lower back) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SCRATCH (little on my back then scratch marks) and RASH (little rash on lower back). At the time of the report, SCRATCH (little on my back then scratch marks) and RASH (little rash on lower back) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant Medications were not provided by the reporter. Treatment Information was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1643265
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: severe headache or migraine; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (severe headache or migraine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (severe headache or migraine). At the time of the report, MIGRAINE (severe headache or migraine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported by the reporter. No treatment medications were provided by the reporter. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1643266
Sex: M
Age: 82
State: FL

Vax Date: 02/24/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: About a month after receiving 2nd dose(in April), he started noticing red marks (burst blood vessels) on both forearms; On his right arm, he has red marks (purple blotchy) about 0.5 inches big/He thought that these blotches may be coming from vaccine/He never had anything like this in the past.; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (About a month after receiving 2nd dose(in April), he started noticing red marks (burst blood vessels) on both forearms) and RASH MACULAR (On his right arm, he has red marks (purple blotchy) about 0.5 inches big/He thought that these blotches may be coming from vaccine/He never had anything like this in the past.) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 031M20A) for COVID-19 vaccination. No medical history was reported. Concomitant products included ACETYLSALICYLIC ACID (ASPIRINE), IRBESARTAN (AVAPRO), CARVEDILOL, ATORVASTATIN and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (About a month after receiving 2nd dose(in April), he started noticing red marks (burst blood vessels) on both forearms) and RASH MACULAR (On his right arm, he has red marks (purple blotchy) about 0.5 inches big/He thought that these blotches may be coming from vaccine/He never had anything like this in the past.). At the time of the report, ERYTHEMA (About a month after receiving 2nd dose(in April), he started noticing red marks (burst blood vessels) on both forearms) and RASH MACULAR (On his right arm, he has red marks (purple blotchy) about 0.5 inches big/He thought that these blotches may be coming from vaccine/He never had anything like this in the past.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment medications were provided. Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow-up received and patient demographics updated.

Other Meds: ASPIRINE; AVAPRO; CARVEDILOL; ATORVASTATIN; VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 1643267
Sex: M
Age: 61
State: TX

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: did not receive the second dose as scheduled; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (did not receive the second dose as scheduled) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M22A) for COVID-19 vaccination. The patient's past medical history included Dialysis (3 times a week) since an unknown date. On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not receive the second dose as scheduled). On 16-Mar-2021, PRODUCT DOSE OMISSION ISSUE (did not receive the second dose as scheduled) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not reported.

Other Meds:

Current Illness: Dialysis (3 times a week)

ID: 1643268
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Fuzzy head; fever; Myalgia; headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Fuzzy head), PYREXIA (fever), MYALGIA (Myalgia ) and HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Fuzzy head), PYREXIA (fever), MYALGIA (Myalgia ) and HEADACHE (headache). At the time of the report, FEELING ABNORMAL (Fuzzy head), PYREXIA (fever), MYALGIA (Myalgia ) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1643269
Sex: M
Age:
State:

Vax Date: 01/01/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: not been feeling well; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not been feeling well) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (not been feeling well). At the time of the report, MALAISE (not been feeling well) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1643270
Sex: U
Age:
State:

Vax Date: 06/17/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of extreme dizziness 7 days after vaccine in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Jun 17, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced extreme dizziness 7 days after vaccine. At the time of the report, extreme dizziness 7 days after vaccine outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information provided.

Other Meds:

Current Illness:

ID: 1643271
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: shot given in shoulder bone; This spontaneous case was reported by an other health care professional and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (shot given in shoulder bone) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (shot given in shoulder bone). At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (shot given in shoulder bone) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1643272
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: vaccine given to 17 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine given to 17 year old) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine given to 17 year old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine given to 17 year old) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. no concomitant and treatment medications reported.

Other Meds:

Current Illness:

ID: 1643273
Sex: U
Age:
State: PR

Vax Date: 06/17/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: vaccines from vials that had been thawed more than 30 days ago were administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccines from vials that had been thawed more than 30 days ago were administered) in a 43-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination. No Medical History information was reported. On 17-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccines from vials that had been thawed more than 30 days ago were administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccines from vials that had been thawed more than 30 days ago were administered) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. No treatment information was provided by the reporter.

Other Meds:

Current Illness:

ID: 1643274
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: low grade fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fever) and CHILLS (chills) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (low grade fever) and CHILLS (chills). At the time of the report, PYREXIA (low grade fever) and CHILLS (chills) outcome was unknown. No relevant concomitant medication was reported. No treatment medication was reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1643275
Sex: U
Age:
State: PR

Vax Date: 06/17/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: vaccines from vials that had been thawed more than 30 days ago were administered; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Jun-2021 and was forwarded to Moderna on 24-Jun-2021. This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccines from vials that had been thawed more than 30 days ago were administered) in a 40-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 3002920) for COVID-19 vaccination. No Medical History information was reported. On 17-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccines from vials that had been thawed more than 30 days ago were administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccines from vials that had been thawed more than 30 days ago were administered) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided. No treatment information was provided by the reporter.

Other Meds:

Current Illness:

ID: 1643276
Sex: F
Age: 41
State: MA

Vax Date: 03/05/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: I was pregnant at the time of both doses, however, I was unaware that I was pregnant when I received the first dose (I was only about 2 weeks pregnant).; Arm pain; Body aches; Fatigue; Nausea; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (I was pregnant at the time of both doses, however, I was unaware that I was pregnant when I received the first dose (I was only about 2 weeks pregnant).), PAIN IN EXTREMITY (Arm pain), LYMPH NODE PAIN (slight swelling and tenderness was noted after second dose), LYMPHADENOPATHY (Sight swelling in the right node) and MYALGIA (Body aches) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Asthma (Patient took increased dose of Advair 4/21 after worsening asthma symptoms over past year.) since 1981, Depression since 2008, Anxiety since 2008, Allergy to nuts (Tree nuts) and Allergy to antibiotic (Z-pack). Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Allergy, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) and ALBUTEROL [SALBUTAMOL] for Asthma, ESCITALOPRAM OXALATE (LEXAPRO) for Depression and Anxiety, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) and MELATONIN for Sleep problem. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 11-Mar-2021, the patient experienced LYMPHADENOPATHY (Sight swelling in the right node). On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (I was pregnant at the time of both doses, however, I was unaware that I was pregnant when I received the first dose (I was only about 2 weeks pregnant).), PAIN IN EXTREMITY (Arm pain), LYMPH NODE PAIN (slight swelling and tenderness was noted after second dose), MYALGIA (Body aches), FATIGUE (Fatigue) and NAUSEA (Nausea). At the time of the report, EXPOSURE DURING PREGNANCY (I was pregnant at the time of both doses, however, I was unaware that I was pregnant when I received the first dose (I was only about 2 weeks pregnant).) outcome was unknown, PAIN IN EXTREMITY (Arm pain), LYMPH NODE PAIN (slight swelling and tenderness was noted after second dose), MYALGIA (Body aches), FATIGUE (Fatigue) and NAUSEA (Nausea) had resolved and LYMPHADENOPATHY (Sight swelling in the right node) had resolved with sequelae. No treatment medications were provided by the reporter. The concomitant product Advair and albuterol inhaler were reported to be taken by inhalation route. The action taken with the suspect drug Moderna COVID-19 vaccine was not applicable. The event swollen lymph nodes recovered with a residual effect as node remained slightly enlarged. This case was linked to MOD-2021-041240 (Patient Link).

Other Meds: ADVAIR; LEXAPRO; ALBUTEROL [SALBUTAMOL]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]; MELATONIN

Current Illness: Allergy to antibiotic (Z-pack); Allergy to nuts (Tree nuts); Anxiety; Asthma (Patient took increased dose of Advair 4/21 after worsening asthma symptoms over past year.); Depression

ID: 1643277
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: My arm has a big rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (My arm has a big rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (My arm has a big rash). At the time of the report, RASH (My arm has a big rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications information were reported. Treatment information was not reported..

Other Meds:

Current Illness:

ID: 1643278
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Report side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Report side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Report side effect). At the time of the report, VACCINATION COMPLICATION (Report side effect) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient called because after receiving the first vaccine side effects, that where not mentioned as normal when giving the vaccine, were developed. Wanted to know if there was any chance of receiving only one dose instead of two doses. no concomitant medications are provided.

Other Meds:

Current Illness:

ID: 1643279
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Vaccine given to 17 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given to 17 year old) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024C21A and 038C21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given to 17 year old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given to 17 year old) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Treatment information was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1643280
Sex: U
Age:
State: PR

Vax Date: 06/17/2021
Onset Date: 06/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: vaccines from vials that had been thawed more than 30 days ago were administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccines from vials that had been thawed more than 30 days ago were administered) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination. No Medical History information was reported. On 17-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccines from vials that had been thawed more than 30 days ago were administered). On 17-Jun-2021, EXPIRED PRODUCT ADMINISTERED (vaccines from vials that had been thawed more than 30 days ago were administered) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided by the reporter. No treatment information were provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow up received included no new significant information. Awaiting translation.

Other Meds:

Current Illness:

ID: 1643281
Sex: F
Age: 48
State: NY

Vax Date: 06/23/2021
Onset Date: 06/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Little cramping and uncomfortable feeling only when urinating and felt burning at the end of the urination; Little tiny light pink in urine/After 30 minutes when urinate again it has little red; Pee more than the usual and this was just after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (Little cramping and uncomfortable feeling only when urinating and felt burning at the end of the urination), CHROMATURIA (Little tiny light pink in urine/After 30 minutes when urinate again it has little red) and POLLAKIURIA (Pee more than the usual and this was just after the vaccine) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051c21a) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included AMLODIPINE for an unknown indication. On 23-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jun-2021, the patient experienced DYSURIA (Little cramping and uncomfortable feeling only when urinating and felt burning at the end of the urination), CHROMATURIA (Little tiny light pink in urine/After 30 minutes when urinate again it has little red) and POLLAKIURIA (Pee more than the usual and this was just after the vaccine). At the time of the report, DYSURIA (Little cramping and uncomfortable feeling only when urinating and felt burning at the end of the urination), CHROMATURIA (Little tiny light pink in urine/After 30 minutes when urinate again it has little red) and POLLAKIURIA (Pee more than the usual and this was just after the vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient took Tylenol right after the vaacination, for unknown indication.

Other Meds: AMLODIPINE

Current Illness:

ID: 1643282
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Does this vaccine affect anyone from having a pregnancy or from becoming a parent; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Does this vaccine affect anyone from having a pregnancy or from becoming a parent) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Does this vaccine affect anyone from having a pregnancy or from becoming a parent). At the time of the report, EXPOSURE DURING PREGNANCY (Does this vaccine affect anyone from having a pregnancy or from becoming a parent) had resolved. Concomitant medications were not reported. No treatment medication details was reported.

Other Meds:

Current Illness:

ID: 1643283
Sex: F
Age:
State: VA

Vax Date: 04/02/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: received the first dose of the Moderna vaccine on 02Apr2021 and has not received the second dose yet; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the first dose of the Moderna vaccine on 02Apr2021 and has not received the second dose yet) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the first dose of the Moderna vaccine on 02Apr2021 and has not received the second dose yet). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the first dose of the Moderna vaccine on 02Apr2021 and has not received the second dose yet) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was mentioned. No treatment medication was mentioned.

Other Meds:

Current Illness:

ID: 1643284
Sex: F
Age: 27
State: IL

Vax Date: 04/23/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: first Moderna COVID-19 dose on 23Apr2021, and hasn't received the second dose yet as she is afraid of needles; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first Moderna COVID-19 dose on 23Apr2021, and hasn't received the second dose yet.) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. No Medical History information was reported. On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (first Moderna COVID-19 dose on 23Apr2021, and hasn't received the second dose yet.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (first Moderna COVID-19 dose on 23Apr2021, and hasn't received the second dose yet.) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment was reported. No concomitant medication was reported. Patient is afraid of needles which is why she hasn't gotten the second dose.

Other Meds:

Current Illness:

ID: 1643285
Sex: M
Age:
State:

Vax Date: 05/25/2021
Onset Date: 06/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: COLD; SWEATING; HEADACHE; This spontaneous case was reported by a patient and describes the occurrence of NASOPHARYNGITIS (COLD), HYPERHIDROSIS (SWEATING) and HEADACHE (HEADACHE) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050C21A and 033C21A) for COVID-19 vaccination. No medical history information was reported. Concomitant products included OLANZAPINE HYDROCHLORIDE for an unknown indication. On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jun-2021, the patient experienced NASOPHARYNGITIS (COLD) and HEADACHE (HEADACHE). 22-Jun-2021, the patient experienced HYPERHIDROSIS (SWEATING). At the time of the report, NASOPHARYNGITIS (COLD), HYPERHIDROSIS (SWEATING) and HEADACHE (HEADACHE) outcome was unknown. No treatment drug details was reported.

Other Meds: OLANZAPINE HYDROCHLORIDE

Current Illness:

ID: 1643286
Sex: F
Age:
State: AR

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Scratchy throat; Swelling of lymph nodes (collar bone, jaw, ribs); Soreness; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (Scratchy throat), LYMPHADENOPATHY (Swelling of lymph nodes (collar bone, jaw, ribs)) and MYALGIA (Soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C27A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROAT IRRITATION (Scratchy throat), LYMPHADENOPATHY (Swelling of lymph nodes (collar bone, jaw, ribs)) and MYALGIA (Soreness). At the time of the report, THROAT IRRITATION (Scratchy throat), LYMPHADENOPATHY (Swelling of lymph nodes (collar bone, jaw, ribs)) and MYALGIA (Soreness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1643287
Sex: F
Age:
State: IN

Vax Date: 05/25/2021
Onset Date: 05/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Shortness of breath; Chest pain; Huge baseball size lump at the injection site was very hard; After second vaccine appeared a huge baseball sized lump at injection site; Huge baseball size lump at the injection site was very sore; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), CHEST PAIN (Chest pain), VACCINATION SITE INDURATION (Huge baseball size lump at the injection site was very hard), VACCINATION SITE SWELLING (After second vaccine appeared a huge baseball sized lump at injection site) and VACCINATION SITE PAIN (Huge baseball size lump at the injection site was very sore) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. o14cz1A and o4ob218) for COVID-19 vaccination. No Medical History information was reported. On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced DYSPNOEA (Shortness of breath), CHEST PAIN (Chest pain), VACCINATION SITE INDURATION (Huge baseball size lump at the injection site was very hard), VACCINATION SITE SWELLING (After second vaccine appeared a huge baseball sized lump at injection site) and VACCINATION SITE PAIN (Huge baseball size lump at the injection site was very sore). On 25-May-2021, DYSPNOEA (Shortness of breath) and CHEST PAIN (Chest pain) had resolved. At the time of the report, VACCINATION SITE INDURATION (Huge baseball size lump at the injection site was very hard), VACCINATION SITE SWELLING (After second vaccine appeared a huge baseball sized lump at injection site) and VACCINATION SITE PAIN (Huge baseball size lump at the injection site was very sore) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant product use was provided by the reporter. No treatment medication was provided. Action take with mRNA-1273 in response to the events were not applicable. On the night of vaccination day she went to the Amita Community Hospital ER, located in Munster, Indiana, with chest pain and shortness of breath, and they took tests. She had a really hard time breathing, and these side effects were resolved, after her release the same day.

Other Meds:

Current Illness:

ID: 1643288
Sex: F
Age: 62
State: MN

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Started getting rash on top of both hands that lasted for months; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Started getting rash on top of both hands that lasted for months) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 040A21A) for COVID-19 vaccination. Concomitant products included LEVOTHYROXINE for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced RASH (Started getting rash on top of both hands that lasted for months). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at a dose of 1 UNK. At the time of the report, RASH (Started getting rash on top of both hands that lasted for months) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment medication include Steroid cream. This case was linked to MOD-2021-235140 (Patient Link).

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1643289
Sex: F
Age:
State: SC

Vax Date: 06/24/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients.; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients.) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination. No Medical History information was reported. On 24-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients.) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant and treatment medications were provided Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow-up information received on 07-jul-2021 contains non significant information as another reporter added.

Other Meds:

Current Illness:

ID: 1643290
Sex: F
Age: 62
State: MN

Vax Date: 02/10/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Biopsy; Result Unstructured Data: Dermatities and a bacterial infection on my skin

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Hypersensitivity; Bacterial infection on skin; Dermatities; Adverse reaction from the covic vaccine; It is all irritated skin; The rash is bumpy with red blotches; They break open and she bleeds when she scratches; itching so bad; Cant Sleep; After 2nd dose, rash progressed to whole body it spread to feet, legs and hands as well / breaking open of skin all over; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Hypersensitivity), SKIN BACTERIAL INFECTION (Bacterial infection on skin), DERMATITIS (Dermatities), VACCINATION COMPLICATION (Adverse reaction from the covic vaccine) and SKIN IRRITATION (It is all irritated skin) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included LEVOTHYROXINE for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Hypersensitivity), SKIN BACTERIAL INFECTION (Bacterial infection on skin), DERMATITIS (Dermatities), VACCINATION COMPLICATION (Adverse reaction from the covic vaccine), SKIN IRRITATION (It is all irritated skin), RASH MACULAR (The rash is bumpy with red blotches), RASH PRURITIC (They break open and she bleeds when she scratches), PRURITUS (itching so bad), INSOMNIA (Cant Sleep) and RASH (After 2nd dose, rash progressed to whole body it spread to feet, legs and hands as well / breaking open of skin all over). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Itching, at a dose of UNK UNK, bid. At the time of the report, HYPERSENSITIVITY (Hypersensitivity), SKIN BACTERIAL INFECTION (Bacterial infection on skin), DERMATITIS (Dermatities), VACCINATION COMPLICATION (Adverse reaction from the covic vaccine), SKIN IRRITATION (It is all irritated skin), RASH MACULAR (The rash is bumpy with red blotches), RASH PRURITIC (They break open and she bleeds when she scratches), PRURITUS (itching so bad), INSOMNIA (Cant Sleep) and RASH (After 2nd dose, rash progressed to whole body it spread to feet, legs and hands as well / breaking open of skin all over) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy: abnormal (abnormal) Dermatities and a bacterial infection on my skin. Steroid cream was also included for the treatment of rash. Patient is taking Vineger soak. This case was linked to MOD-2021-235075 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Patient demographics were updated. Treatment medication Cetirizine was added. New events "Itching so bad", "dermatitis", "bacterial infection on skin", "adverse reaction from the covid vaccine", "hypersensitivity", "can't sleep" were added.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1643291
Sex: F
Age:
State: MD

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: pregnant after receiving 1st dose of Moderna COVID-19 vaccine; This spontaneous prospective pregnancy case was reported by a pharmacist and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant after receiving 1st dose of Moderna COVID-19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (pregnant after receiving 1st dose of Moderna COVID-19 vaccine). At the time of the report, EXPOSURE DURING PREGNANCY (pregnant after receiving 1st dose of Moderna COVID-19 vaccine) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication details was reported. No treatment medication details was reported.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am